The prevalence of human T ceil lymphoma virus type 1 (HTLV-I) was studied among patients with endogenous uveitis. Twelve (15.8%) of 76 uveitis patients with known aetiology or clinical entity were seropositive, the prevalence being comparable with that in the general population of the southwestern area of Japan where HTLV-I is highly endemic. In the comparison, 32 (41-0%) of 78 patients with aetiology or entity undefined uveitis were seropositive for HTLV-I, which indicated a signifcantly higher seroprevalence than controls matched for sex and age. The 32 cases of clinical entity undefined, HTLV-I positive uveitis were characterised by acute granulomatous or non-granulomatous uveal reactions which were accompanied by vitreous opacities and retinal vasculitis. The uveal inflammatory and retinal vascular changes responded weli to topical and/or systemic corticosteroids and resolved in a few weeks in the majority of cases with favourable visual outcome. The disease affected one or both eyes, and eight cases (25%) showed recurrence within a year. The general condition of the patients remained well otherwise during a foliow up study (mean follow up time 15*4 months), except for three cases with a possible association of hyperthyroidism. These findings provide additional information favouring an association between HTLV-I and isolated uveitis, a new disease entity which should be termed HTLV-I-associated uveitis.
Human T cell lymphoma virus type 1 (HTLV-I), a retrovirus distinct from human immunodeficiency virus (HIV), has been shown to cause at least two systemic diseases. One is a haematological malignancy adult T cell leukaemia/ lymphoma in which HTLV-I proviral DNA is integrated in the proliferating T lymphocytes. 2 Ocular manifestations of the haematological disease include intraocular infiltration of malignant T lymphocytes, intraocular opportunistic infection, such as cytomegalovirus retinitis, and adnexal lymphoma. 35 The other disease is a chronic progressive neurological disease called HTLV-I-associated myelopathy6 or tropical spastic paraparesis.7 Ocular manifestations of the neurological disease include retinal vasculitis, retinochoroidal degenerative changes, and uveitis.- '2 Our previous study showed a significantly higher prevalence of HTLV-I infection in a series of uveitis patients whose aetiology or clinical entity was undefined. It suggested an association between HTLV-I and isolated uveitis, and we proposed the name of 'HTLV-I-associated uveitis (HAU)' for this clinical entity.'3 However, it has remained to be established whether HTLV-1 is the causative agent of uveitis in these patients and whether such uveitis is predictive of the development of HTLV-Iassociated haematological or neurological disease. '4 We have enlarged the study of uveitis patients to answer these questions and we report the results here.
Materials and methods
We studied a consecutive series of 154 patients with endogenous uveitis. There were 75 males and 79 females, and ranged in age from 12 to 87 years (mean 47-0 years, median 48 Table 2 ) showed a discrete, round, white lesion located in the superficial retinal layer of the macula.
Clinical course and visual outcome As shown in Case 4 A 50-year-old woman claimed acute blurring of the right vision. Corrected visual acuity was right eye 0 04, left eye 0 9. The right eye had white keratic precipitates, 2+ cells in the anterior chamber and dense vitreous opacities so that the fundus was barely visible. Mild oedema of the posterior retina and punctate, white-yellow deposits over the retinal arteries were observed. Regression of the keratic precipitates and vitreous opacities in 2 weeks with topical and systemic corticosteroids was followed by manifestation of multiple cotton wool spots in the posterior fundus and cystoid macular oedema. Corticosteroid therapy was continued, and the cotton wool spots and cystoid macular oedema were almost resolved within 10 weeks with recovery of normal visual acuity, but white, punctate deposits were retained on the retinal arteries. Nakao, Ohba 
SYSTEMIC DISEASE AND LABORATORY STI
Aside from coincident systemic diso majority of the 32 patients remained unremarkable, and patients did not sign of HTLV-I-associated haemato neurological disorders. There were r findings in routine laboratory studi typing performed in 16 patients sJ specific antigen. Noticeably, three (cases 6, 14, 17, Whether isolated uveitis predates HTLV-Inptomatic associated systemic diseases remains to be eluciuveitis of dated. In the present follow up study (mean 15 4 months, median 3-0 months), no patient with isolated uveitis developed haematological or neurological disease. Aside from coincident systemic diseases in adults, it is noticeable that mild hyperthyroidism was found in three patients. A total of nine cases of association between uveitis and hyperthyroidism is described in the literature. It is interesting that one of the cases was infected with HTLV-I'8 and that, although the remaining cases were not examined for HTLV-I, they were residents of the southwestern area ofJapan where HTLV-I is endemic.1920
The pathomechanism of HTLV-I-associated uveitis is not clear. Our previous assessment of aqueous antibodies to HTLV-I did not provide any evidence for intraocular proliferation of the retrovirus.'2 Response to corticosteroids and the recurrent nature of the disease suggest an undefined immune mechanism similar to that proposed for HTLV-I-associated myelopathy and other HTLV-I-related disease complexes615 16; there was no specific HLA antigen in the present series of HTLV-I-associated uveitis, and the serum titre of HTLV-I-associated uveitis was comparable with that of asymptomatic carriers.
HTLV-I is widespread in the world, with endemic areas in Japan, the Caribbean, Central Africa, and South America. Many patients with HTLV-I-associated myelopathy or adult T cell leukaemia/lymphoma are found not only in these endemic areas but also among immigrants in Europe and North America. This study indicates that assessment for HTLV-I infection would be worthwhile in those patients whose uveitis remains undefined for aetiology or clinical entity. Further studies are needed to support our view that HTLV-I is a causative agent of isolated uveitis.
This study was supported by grants-in-aid for scientific research (No 03771230, 03454417) from the Ministry of Education, Science and Culture of Japan.
